Simplex Trading’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-26,577
| Closed | -$3.02M | – | 9398 |
|
|
2025
Q2 | $2.95M | Buy |
+26,577
| New | +$2.83M | ﹤0.01% | 1772 |
|
|
2025
Q1 | – | Sell |
-32,076
| Closed | -$3.31M | – | 8892 |
|
|
2024
Q4 | $2.96M | Sell |
32,076
-27,777
| -46% | -$2.5M | ﹤0.01% | 1856 |
|
|
2024
Q3 | $5.02M | Sell |
59,853
-92,589
| -61% | -$7.06M | ﹤0.01% | 1488 |
|
|
2024
Q2 | $10.5M | Buy |
152,442
+51,199
| +51% | +$3.42M | 0.01% | 989 |
|
|
2024
Q1 | $7.42M | Buy |
+101,243
| New | +$7.79M | ﹤0.01% | 1316 |
|
|
2023
Q4 | – | Sell |
-78,758
| Closed | -$6.13M | – | 9163 |
|
|
2023
Q3 | $5.9M | Sell |
78,758
-43,557
| -36% | -$3.35M | ﹤0.01% | 1229 |
|
|
2023
Q2 | $9.43M | Buy |
+122,315
| New | +$9.76M | 0.01% | 929 |
|
|
2022
Q3 | – | Sell |
-50,325
| Closed | -$3.17M | – | 10256 |
|
|
2022
Q2 | $3.11M | Buy |
+50,325
| New | +$3.12M | ﹤0.01% | 1469 |
|
|
2022
Q1 | – | Sell |
-68,715
| Closed | -$4.39M | – | 10740 |
|
|
2021
Q4 | $4.99M | Sell |
68,715
-41,827
| -38% | -$2.88M | 0.01% | 1206 |
|
|
2021
Q3 | $7.64M | Buy |
110,542
+23,394
| +27% | +$1.64M | 0.01% | 885 |
|
|
2021
Q2 | $6M | Sell |
87,148
-53,052
| -38% | -$3.54M | 0.01% | 1034 |
|
|
2021
Q1 | $0 | Sell |
140,200
-125,188
| -47% | -$8.07M | ﹤0.01% | 9226 |
|
|
2020
Q4 | $15.5M | Buy |
+265,388
| New | +$16M | 0.02% | 426 |
|
|
2020
Q3 | – | Sell |
-100
| Closed | -$6.93K | – | 8035 |
|
|
2020
Q2 | $7K | Sell |
100
-160,871
| -100% | -$12.3M | ﹤0.01% | 6811 |
|
|
2020
Q1 | $12M | Buy |
160,971
+23,574
| +17% | +$1.63M | 0.02% | 348 |
|
|
2019
Q4 | $8.93M | Buy |
137,397
+66,439
| +94% | +$4.33M | 0.02% | 509 |
|
|
2019
Q3 | $4.5M | Buy |
70,958
+62,532
| +742% | +$4.09M | 0.01% | 775 |
|
|
2019
Q2 | $569K | Sell |
8,426
-29,291
| -78% | -$1.93M | ﹤0.01% | 2449 |
|
|
2019
Q1 | $2.45M | Buy |
37,717
+18,841
| +100% | +$1.25M | 0.01% | 1196 |
|
|
2018
Q4 | $1.18M | Buy |
18,876
+1,476
| +8% | +$103K | ﹤0.01% | 1501 |
|
|
2018
Q3 | $1.34M | Sell |
17,400
-31,606
| -64% | -$2.39M | ﹤0.01% | 1586 |
|
|
2018
Q2 | $3.47M | Buy |
+49,006
| New | +$3.46M | 0.01% | 762 |
|
|
2018
Q1 | – | Sell |
-78,525
| Closed | -$6.24M | – | 6381 |
|
|
2017
Q4 | $5.63M | Buy |
+78,525
| New | +$5.96M | 0.24% | 76 |
|
|
2017
Q3 | – | Sell |
-64,544
| Closed | -$4.94M | – | 6140 |
|
|
2017
Q2 | $4.57M | Sell |
64,544
-414,502
| -87% | -$27.6M | 0.2% | 83 |
|
|
2017
Q1 | $32.5M | Buy |
479,046
+170,682
| +55% | +$12M | 1.41% | 7 |
|
|
2016
Q4 | $22.1M | Buy |
308,364
+52,059
| +20% | +$3.87M | 1.32% | 9 |
|
|
2016
Q3 | $20.3M | Buy |
256,305
+212,451
| +484% | +$17.3M | 1.37% | 5 |
|
|
2016
Q2 | $3.66M | Buy |
43,854
+27,576
| +169% | +$2.45M | 0.24% | 67 |
|
|
2016
Q1 | $1.5M | Sell |
16,278
-74,563
| -82% | -$6.72M | 0.12% | 156 |
|
|
2015
Q4 | $9.19M | Sell |
90,841
-15,221
| -14% | -$1.58M | 0.72% | 18 |
|
|
2015
Q3 | $10.4M | Buy |
+106,062
| New | +$11.8M | 0.76% | 17 |
|
|
2015
Q2 | – | Sell |
-1,121
| Closed | -$122K | – | 5404 |
|
|
2015
Q1 | $110K | Sell |
1,121
-318,305
| -100% | -$32.3M | 0.01% | 1041 |
|
|
2014
Q4 | $30.1M | Buy |
+319,426
| New | +$33M | 3.65% | 2 |
|
Other funds holding GILD
VCM
VPM
Simplex Trading's GILD Position: Q3 2025 in Review
Simplex Trading sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 26,577 shares — an estimated $3.02M sold.
Simplex Trading first reported a position in GILD in Q4 2014 and held it in 33 quarters. The position peaked at $32.5M in Q1 2017. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Simplex Trading reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 26,577 Gilead Sciences shares in Q3 2025, an estimated $3.02M.
- Simplex Trading first reported a position in Gilead Sciences in Q4 2014 and held it in 33 quarters.
- Simplex Trading's Gilead Sciences position peaked at $32.5M in Q1 2017.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.